Outlines

1

2

3

4

5

6

7

8

9


 

Comments

Post a Comment

Popular posts from this blog

Evaluation of the Xpert MTB Host Response assay for the triage of patients [TB0108]

A triage test with a minimum sensitivity of 90% and specificity of 70%, meeting predefined operational targets, could help reduce underdiagnosis and misdiagnosis of tuberculosis, decrease delays in starting treatment, and lower the cost and infrastructure demands of current gold-standard sputum-based tests in high-burden settings.  Sweeney and colleagues validated a three-gene host blood signature, utilizing blood mRNA to measure markers associated with the host inflammatory response, which can differentiate tuberculosis disease from other conditions. This signature has been developed into an automated, blood-based quantitative PCR test on the GeneXpert platform, generating a TB Score based on the cycle threshold of expressed genes. Early studies from stored samples and interim results from a multisite study suggest that this test may achieve the WHO's target product profile minimum accuracy threshold for a tuberculosis triage test. We aimed to prospectively evaluate the diagnostic...
Read more

Relationship between the length of treatment for PTB and Hb levels [TB0103]

The notification rate for all tuberculosis cases in Central Java Province in 2022 was 179 per 100,000 population, an increase from 110 per 100,000 population in 2021. Semarang City continues to rank as the highest regency/city, with a Case Notification Rate (CNR) for all TB cases at 348 per 100,000 population. Kedungmundu District has the highest number of pulmonary TB cases, with a total of 186 cases, followed by Bangetayu District with 158 pulmonary TB cases. TB treatment begins with an intensive phase lasting for the first two months, potentially followed by an advanced phase. Long-term TB treatment often leads to issues with patient compliance. Noncompliance in tuberculosis treatment can have a negative impact on clinical outcomes and public health. Hematological abnormalities are common in TB patients, including leukocytosis, monocytosis, lymphocytosis, thrombocytosis, lymphopenia, and anemia. Anti-TB drugs such as isoniazid and rifampicin can cause hemolytic anemia or metabolic d...
Read more

Epidemiology, pathogenesis and therapeutic management of PTB-DM [TB0105]

Diabetes mellitus (DM) poses a significant health risk, leading to complications in multiple organs, including the lungs. Lung function is notably reduced in DM patients, with pulmonary complications commonly observed. The comorbidity of pulmonary tuberculosis (PTB) and DM is high, with a global prevalence of about 13.73%. PTB also raises the risk of developing DM, with higher DM prevalence in PTB patients compared to those without PTB. DM increases susceptibility to PTB by disrupting innate and adaptive immune responses, while PTB impairs islet cell function through islet amyloidosis. Anti-tuberculosis drugs further affect glucose homeostasis by disrupting liver and kidney functions. Hyperglycemia in DM affects macrophage phagocytosis by altering recognition receptor expression, impairing immunity against PTB. Specifically, hyperglycemia reduces the phagocytic function of alveolar macrophages. Infection with Mycobacterium tuberculosis triggers dendritic cell maturation and migration,...
Read more